Department Of Justice Joins Lawsuits Filed Over Alleged Illegal Marketing Of Heart Failure Medication Natrecor

Main Category: Cardiovascular / Cardiology
Also Included In: Litigation / Medical Malpractice;  Heart Disease
Article Date: 23 Feb 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The Department of Justice on Thursday announced plans to join two whistleblower lawsuits filed against Johnson & Johnson subsidiary Scios over allegations that the company illegally marketed the heart failure medication Natrecor for unapproved uses and defrauded Medicare and other federal health care programs, the San Francisco Chronicle reports. FDA in 2001 approved Natrecor for use in hospital patients who experienced shortness of breath caused by acute congestive heart failure (Egelko, San Francisco Chronicle, 2/20).

According to the lawsuits, filed in 2005 in U.S. District Court for the Northern District of California by former Scios sales managers Joe Strom and Jeffrey Smith, the company since 2001 has marketed Natrecor for use in outpatients who have less severe heart failure. In court documents unsealed on Thursday, the plaintiff in one of the lawsuits alleges that "upper management has always permitted and encouraged active off-label marketing" (Wang/Kendall, Wall Street Journal, 2/20). Marcella Auerbach, an attorney for one of the plaintiffs, said that Scios and J&J have collected hundreds of millions of dollars in reimbursements from Medicare and other federal health programs for unapproved uses of Natrecor (San Francisco Chronicle, 2/20).

Charles Miller, a spokesperson for the civil division at DOJ, said, "Our investigation showed what we believed to have been off-label usage," adding, "As a result, we've joined the suit."

Ernie Knewitz, a spokesperson for J&J, said that the company had "reviewed the allegations thoroughly and will be prepared to address them through the courts" (Wall Street Journal, 2/20).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Natrecor.


Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Department Of Justice Joins Lawsuits Filed Over Alleged Illegal Marketing Of Heart Failure Medication Natrecor." Medical News Today. MediLexicon, Intl., 23 Feb. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/139876.php>

APA
Kaiser. (2009, February 23). "Department Of Justice Joins Lawsuits Filed Over Alleged Illegal Marketing Of Heart Failure Medication Natrecor." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/139876.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »